What is the appropriate initial empiric treatment and diagnostic workup for a patient with infectious cerebral vasculitis?

Infectious Cerebral Vasculitis: Initial Management

For suspected infectious cerebral vasculitis, immediately initiate empiric intravenous aciclovir (10 mg/kg three times daily) while pursuing urgent diagnostic workup, and add corticosteroids (60-80 mg prednisolone daily for 3-5 days) specifically when vasculitic features are present on imaging. 1

Immediate Empiric Treatment

Antiviral Therapy

• Start IV aciclovir 10 mg/kg three times daily within 6 hours of presentation if viral encephalitis with vasculitis is suspected 1, 2
• For VZV vasculitis specifically, consider 10-15 mg/kg three times daily given VZV's lower sensitivity to aciclovir 1
• Continue for 14-21 days, adjusting dose for renal impairment 1, 2
• Do not delay treatment waiting for confirmatory testing—CSF PCR remains positive for 7-10 days even after starting aciclovir 2

Corticosteroid Use: A Critical Decision Point

The evidence strongly supports corticosteroids when vasculitic features are documented 1, 2, 1:

• If imaging shows vasculitic changes (arterial beading, stenosis, vessel wall enhancement): Add prednisolone 60-80 mg daily for 3-5 days 1
• For VZV vasculopathy with stroke: corticosteroids are recommended given the inflammatory pathogenesis 2
• For HSV encephalitis without vasculitis: corticosteroids remain controversial and should not be used routinely 1

The distinction matters: vasculitis involves inflammatory vessel wall damage requiring immunosuppression, whereas pure viral encephalitis may theoretically worsen with steroids facilitating viral replication 1.

Urgent Diagnostic Workup

Neuroimaging (Perform Immediately)

• MRI with MRA or CTA with 3D reconstruction as first-line 1, 3
• Look for specific vasculitic features:
  • Arterial beading, stenosis, or irregularities 3, 4, 5
  • Vessel wall thickening and enhancement 4, 5
  • Multiple infarcts in different vascular territories 5, 6
  • Mycotic aneurysms (particularly with bacterial causes) 7
• If initial imaging negative but high suspicion persists, conventional 4-vessel DSA may be reasonable 3, 7
• Repeat imaging in 2-4 weeks if clinical deterioration occurs 7

Lumbar Puncture (Unless Contraindicated)

Obtain CSF for:

• VZV-specific testing: Anti-VZV IgG (highest sensitivity), IgM, and PCR 3
• HSV PCR 1
• Bacterial culture and Gram stain
• Fungal studies (cryptococcal antigen, culture)
• Syphilis serology (VDRL)
• Tuberculosis testing if chronic meningitis pattern
• Cell count, protein, glucose 8, 9

Critical caveat: Negative VZV PCR does not exclude VZV vasculitis—anti-VZV IgG is more sensitive 3. If suspicion remains high, treat empirically.

Blood Work

• HIV testing (HIV vasculopathy requires different management) 3
• Blood cultures if bacterial etiology suspected
• Syphilis serology
• Hepatitis B and C serology 10

Pathogen-Specific Considerations

VZV Vasculitis (Most Common Viral Cause)

• Aciclovir 10-15 mg/kg TID for 14 days PLUS corticosteroids 1, 3
• Can present with or without preceding rash 3, 11
• In HIV patients, may require 30 mg/kg/day aciclovir 11

Bacterial Meningitis with Vasculitis

• Streptococcus pneumoniae: High-dose antibiotics (meropenem 1g TID + vancomycin 0.5g QID) plus dexamethasone 8, 9, 12
• Consider antibiotic resistance patterns 12
• Delayed cerebral infarction can occur days to weeks after initial improvement—maintain vigilance 8, 9

Neurosyphilis

• Treat underlying infection per standard protocols 3

Fungal (Aspergillus, Mucormycosis, Cryptococcus)

• Requires specific antifungal therapy 10, 4, 12
• Often contiguous spread from sinuses/orbit 10

HIV Vasculopathy

• Daily aspirin plus combined antiretroviral therapy 3
• Different pathophysiology than direct viral invasion

Critical Care Management

Patients require ICU-level monitoring for 1:

• Airway protection if consciousness declining
• Management of raised intracranial pressure
• Seizure control
• Electrolyte monitoring (aciclovir can cause nephropathy in 20% after 4 days) 2
• Cerebral perfusion pressure optimization

Common Pitfalls to Avoid

1. Waiting for confirmatory testing before starting aciclovir—mortality increases significantly with delays beyond 48 hours 1, 2
2. Using corticosteroids indiscriminately—reserve for documented vasculitic features, not routine HSV encephalitis 1
3. Stopping workup after starting empiric treatment—continue pursuing specific diagnosis as it guides duration and adjunctive therapy 1
4. Single negative imaging study—vasculitis can develop during treatment; repeat if clinical deterioration 7
5. Inadequate aciclovir dosing or duration—underdosing may contribute to vasculitic complications 8
6. Rapid steroid taper—delayed tapering appears beneficial for preventing delayed cerebral infarction 9

Specialist Consultation

• Neurological specialist opinion within 24 hours 1
• Infectious disease consultation for pathogen-specific management 3
• Consider transfer to neuroscience center if diagnosis unclear or patient deteriorating 1

Follow-up Considerations

• Repeat LP at 14-21 days to confirm CSF clearance of HSV/VZV 2
• Serial imaging to monitor for mycotic aneurysms (can rupture even after treatment completion) 7
• Prolonged aciclovir courses may be needed in immunocompromised patients 1